Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol
出版年份 2017 全文链接
标题
Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol
作者
关键词
-
出版物
NEUROPSYCHOPHARMACOLOGY
Volume 43, Issue 1, Pages 142-154
出版商
Springer Nature
发表日期
2017-09-07
DOI
10.1038/npp.2017.209
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The current status of artisanal cannabis for the treatment of epilepsy in the United States
- (2017) Dustin Sulak et al. EPILEPSY & BEHAVIOR
- Cannabinoids in treatment-resistant epilepsy: A review
- (2017) Brooke K. O'Connell et al. EPILEPSY & BEHAVIOR
- Behavioral Determinants of Cannabinoid Self-Administration in Old World Monkeys
- (2017) William S John et al. NEUROPSYCHOPHARMACOLOGY
- Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex—Possible involvement of 5-HT1A and CB1 receptors
- (2016) A.G. Sartim et al. BEHAVIOURAL BRAIN RESEARCH
- Enhanced discriminative stimulus effects of Δ9-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys
- (2016) Lance R. McMahon DRUG AND ALCOHOL DEPENDENCE
- Sex-dependent effects of cannabis-induced analgesia
- (2016) Ziva D. Cooper et al. DRUG AND ALCOHOL DEPENDENCE
- Acute and chronic effects of cannabidiol on Δ⁹-tetrahydrocannabinol (Δ⁹-THC)-induced disruption in stop signal task performance.
- (2016) David S. Jacobs et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Are IQ and educational outcomes in teenagers related to their cannabis use? A prospective cohort study
- (2016) C Mokrysz et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Inhaled delivery of Δ 9 -tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology
- (2016) Jacques D. Nguyen et al. NEUROPHARMACOLOGY
- Impact of adolescent marijuana use on intelligence: Results from two longitudinal twin studies
- (2016) Nicholas J. Jackson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ9-tetrahydrocannabinol in Sprague-Dawley rats
- (2015) Michael A Taffe et al. BRITISH JOURNAL OF PHARMACOLOGY
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neural correlates of interactions between cannabidiol and Δ9-tetrahydrocannabinol in mice: implications for medical cannabis
- (2015) S M Todd et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption
- (2015) Cristina A.J. Stern et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users
- (2015) Chandni Hindocha et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Endocannabinoid signalling in reward and addiction
- (2015) Loren H. Parsons et al. NATURE REVIEWS NEUROSCIENCE
- Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis
- (2015) Margaret Haney et al. NEUROPSYCHOPHARMACOLOGY
- Effects of Fatty Acid Amide Hydrolase (FAAH) Inhibitors in Non-Human Primate Models of Nicotine Reward and Relapse
- (2015) Zuzana Justinova et al. NEUROPSYCHOPHARMACOLOGY
- Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum
- (2015) Matthijs G. Bossong et al. PSYCHOPHARMACOLOGY
- A systematic review of the antipsychotic properties of cannabidiol in humans
- (2015) Tabitha A. Iseger et al. SCHIZOPHRENIA RESEARCH
- The case for medical marijuana in epilepsy
- (2014) Edward Maa et al. EPILEPSIA
- Cannabinoid Modulation of Functional Connectivity within Regions Processing Attentional Salience
- (2014) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model
- (2014) Timothy W. Lefever et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- A vapourized Δ9-tetrahydrocannabinol (Δ9-THC) delivery system part II: Comparison of behavioural effects of pulmonary versus parenteral cannabinoid exposure in rodents
- (2014) Laurie A. Manwell et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Cannabidiol attenuates deficits of visuospatial associative memory induced by Δ9tetrahydrocannabinol
- (2013) M Jerry Wright et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience
- (2013) M.V. Fogaça et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cannabidiol reverses the mCPP-induced increase in marble-burying behavior
- (2013) Mirella Nardo et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity
- (2013) Vicky Katsidoni et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Spicing things up: synthetic cannabinoids
- (2013) Max Spaderna et al. PSYCHOPHARMACOLOGY
- Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
- (2012) Amir Englund et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Does olanzapine inhibit the psychomimetic effects of Δ9-tetrahydrocannabinol?
- (2012) Daniël Kleinloog et al. JOURNAL OF PSYCHOPHARMACOLOGY
- On Disruption of Fear Memory by Reconsolidation Blockade: Evidence from Cannabidiol Treatment
- (2012) Cristina A J Stern et al. NEUROPSYCHOPHARMACOLOGY
- Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
- (2012) A. C. Campos et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Persistent cannabis users show neuropsychological decline from childhood to midlife
- (2012) M. H. Meier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Subjective and Physiological Effects After Controlled Sativex and Oral THC Administration
- (2011) E L Karschner et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Heterogeneity in the composition of marijuana seized in California
- (2011) James Richard Burgdorf et al. DRUG AND ALCOHOL DEPENDENCE
- Sativex®(tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data
- (2011) Patrick Vermersch Expert Review of Neurotherapeutics
- Synthetic delta-9-tetrahydrocannabinol elicits schizophrenia-like negative symptoms which are distinct from sedation
- (2011) P. D. Morrison et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: Implications for endocannabinoid control of hippocampal neural plasticity
- (2011) Robert E. Hampson et al. NEUROPHARMACOLOGY
- Δ9-Tetrahydrocannabinol attenuates MDMA-induced hyperthermia in rhesus monkeys
- (2011) M.A. Taffe NEUROSCIENCE
- Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential
- (2011) Andreas M. Stadelmann et al. NEUROSCIENCE LETTERS
- Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being
- (2011) C. J. A. Morgan et al. PSYCHOLOGICAL MEDICINE
- Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats
- (2011) Charlotte Klein et al. PSYCHOPHARMACOLOGY
- Interaction between cannabidiol (CBD) and ∆9-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids
- (2011) Antonio Waldo Zuardi et al. PSYCHOPHARMACOLOGY
- Cannabis with high cannabidiol content is associated with fewer psychotic experiences
- (2011) Christian D. Schubart et al. SCHIZOPHRENIA RESEARCH
- Modulation of NMDA and AMPA-mediated synaptic transmission by CB1 receptors in frontal cortical pyramidal cells
- (2010) Qiang Li et al. BRAIN RESEARCH
- Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation
- (2010) I Magen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Animal models of cannabinoid reward
- (2010) Leigh V Panlilio et al. BRITISH JOURNAL OF PHARMACOLOGY
- Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action
- (2010) Sabatino Maione et al. BRITISH JOURNAL OF PHARMACOLOGY
- Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
- (2010) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- Plasma Cannabinoid Pharmacokinetics following Controlled Oral 9-Tetrahydrocannabinol and Oromucosal Cannabis Extract Administration
- (2010) E. L. Karschner et al. CLINICAL CHEMISTRY
- Retrograde Endocannabinoid Signaling Reduces GABAergic Synaptic Transmission to Gonadotropin-Releasing Hormone Neurons
- (2010) Imre Farkas et al. ENDOCRINOLOGY
- Central nervous system effects of haloperidol on THC in healthy male volunteers
- (2010) M Liem-Moolenaar et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors
- (2010) Felipe V Gomes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
- (2010) Celia JA Morgan et al. NEUROPSYCHOPHARMACOLOGY
- Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
- (2009) Paolo Fusar-Poli et al. ARCHIVES OF GENERAL PSYCHIATRY
- 5-HT1Areceptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats
- (2009) Leonardo B.M. Resstel et al. BRITISH JOURNAL OF PHARMACOLOGY
- Emerging strategies for exploiting cannabinoid receptor agonists as medicines
- (2009) Roger G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- Modulation of effective connectivity during emotional processing by Δ9-tetrahydrocannabinol and cannabidiol
- (2009) Paolo Fusar-Poli et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Non-CB1, Non-CB2 Receptors for Endocannabinoids, Plant Cannabinoids, and Synthetic Cannabimimetics: Focus on G-protein-coupled Receptors and Transient Receptor Potential Channels
- (2009) Luciano De Petrocellis et al. Journal of Neuroimmune Pharmacology
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- (2009) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol reverses the reduction in social interaction produced by low dose Δ9-tetrahydrocannabinol in rats
- (2009) Daniel Thomas Malone et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning
- (2009) P. D. Morrison et al. PSYCHOLOGICAL MEDICINE
- Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
- (2009) Angelo A. Izzo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition
- (2008) Stefan J. Borgwardt et al. BIOLOGICAL PSYCHIATRY
- Behavioral and temperature effects of delta 9-tetrahydrocannabinol in human-relevant doses in rats
- (2008) Michael S. Smirnov et al. BRAIN RESEARCH
- Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
- (2008) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Δ9-tetrahydrocannabinol
- (2008) Robert E. Vann et al. DRUG AND ALCOHOL DEPENDENCE
- Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
- (2008) Alline Cristina Campos et al. PSYCHOPHARMACOLOGY
- Cannabidiol potentiates pharmacological effects of Δ9-tetrahydrocannabinol via CB1 receptor-dependent mechanism
- (2007) Kazuhide Hayakawa et al. BRAIN RESEARCH
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- CB2receptors in the brain: role in central immune function
- (2007) G A Cabral et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More